Association Between Intraocular Pressure and Risk Factors for Metabolic Syndrome in Korea.
Jun Young Lee1, Myung Ho Cho1, Jiwoong Lee1,2
1Department of Ophthalmology, Pusan National University School of Medicine, Busan, Korea.
Metabolic syndrome risk factors, especially abdominal obesity, are linked to higher intraocular pressure (IOP) and ocular hypertension (OHT). Regular IOP screening is crucial for individuals with metabolic syndrome to prevent glaucoma progression.
Area of Science:
- Ophthalmology
- Metabolic Health
- Public Health
Background:
- Glaucoma, a leading cause of blindness, is linked to elevated intraocular pressure (IOP).
- Metabolic syndrome, characterized by obesity, hypertension, hyperglycemia, and dyslipidemia, is associated with increased IOP.
- This study examines the relationship between metabolic syndrome risk factors and IOP in Korean adults.
Purpose of the Study:
- To investigate the association between metabolic syndrome risk factors and intraocular pressure (IOP).
- To determine the relationship between specific metabolic syndrome components and ocular hypertension (OHT).
Main Methods:
- Analysis of data from 1,896 Korean adults (aged 19-59) from the 2021 Korea National Health and Nutrition Examination Survey.
- Exclusion of participants with glaucoma, prior eye surgery, or glaucoma medication use.
- Multivariate logistic regression used to assess associations between metabolic syndrome risk factors (blood pressure, glucose, insulin resistance, BMI, abdominal obesity, triglycerides, HDL) and OHT.
Main Results:
- Participants with metabolic syndrome had significantly higher mean IOP than the normal group (16.05 vs. 15.33 mmHg).
- Hyperglycemia and hypertriglyceridemia were significantly associated with higher IOP.
- Abdominal obesity showed a strong association with ocular hypertension (OR, 2.90; 95% CI, 1.35-6.23).
Conclusions:
- Metabolic syndrome risk factors, particularly abdominal obesity, are significantly associated with ocular hypertension.
- Regular IOP screening is recommended for individuals with metabolic syndrome to mitigate glaucoma progression risks.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Coronary Artery Disease I: Introduction
Angle Closure Glaucoma: Treatment
